| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Living Donors | 56 | 2022 | 160 | 15.210 |
Why?
|
| Kidney Transplantation | 73 | 2023 | 839 | 12.510 |
Why?
|
| Tissue and Organ Procurement | 38 | 2020 | 164 | 9.010 |
Why?
|
| Tissue Donors | 22 | 2022 | 195 | 5.750 |
Why?
|
| Organ Transplantation | 17 | 2021 | 110 | 4.170 |
Why?
|
| Liver Transplantation | 18 | 2022 | 400 | 3.980 |
Why?
|
| Nephrectomy | 12 | 2020 | 103 | 3.910 |
Why?
|
| Kidney Failure, Chronic | 22 | 2023 | 365 | 3.720 |
Why?
|
| Waiting Lists | 22 | 2022 | 104 | 3.230 |
Why?
|
| Quality of Life | 25 | 2020 | 1515 | 3.220 |
Why?
|
| Health Knowledge, Attitudes, Practice | 16 | 2022 | 767 | 2.640 |
Why?
|
| Decision Making | 12 | 2018 | 410 | 2.570 |
Why?
|
| Tissue and Organ Harvesting | 8 | 2019 | 49 | 2.440 |
Why?
|
| Attitude to Health | 17 | 2020 | 403 | 2.210 |
Why?
|
| Family | 15 | 2013 | 293 | 2.150 |
Why?
|
| Donor Selection | 13 | 2022 | 29 | 2.120 |
Why?
|
| Surveys and Questionnaires | 37 | 2021 | 2800 | 2.080 |
Why?
|
| Biomedical Research | 6 | 2019 | 310 | 1.900 |
Why?
|
| Patient Education as Topic | 10 | 2015 | 425 | 1.840 |
Why?
|
| Humans | 180 | 2023 | 68618 | 1.760 |
Why?
|
| Transplant Recipients | 10 | 2020 | 109 | 1.760 |
Why?
|
| Patient Acceptance of Health Care | 5 | 2020 | 468 | 1.690 |
Why?
|
| Adaptation, Psychological | 20 | 2013 | 447 | 1.630 |
Why?
|
| Renal Insufficiency | 5 | 2018 | 121 | 1.600 |
Why?
|
| Apolipoprotein L1 | 3 | 2022 | 16 | 1.600 |
Why?
|
| Middle Aged | 83 | 2021 | 21147 | 1.550 |
Why?
|
| Healthcare Disparities | 8 | 2023 | 378 | 1.530 |
Why?
|
| Male | 115 | 2021 | 37321 | 1.510 |
Why?
|
| Female | 117 | 2021 | 38074 | 1.500 |
Why?
|
| Caregivers | 8 | 2011 | 365 | 1.430 |
Why?
|
| Adult | 79 | 2022 | 21403 | 1.420 |
Why?
|
| Fatigue | 4 | 2019 | 132 | 1.400 |
Why?
|
| Hepatitis C | 3 | 2022 | 114 | 1.390 |
Why?
|
| Lung Transplantation | 6 | 2007 | 88 | 1.290 |
Why?
|
| Affect | 7 | 2021 | 218 | 1.220 |
Why?
|
| Health Education | 8 | 2020 | 279 | 1.210 |
Why?
|
| Stress, Psychological | 14 | 2014 | 824 | 1.180 |
Why?
|
| Kidney | 9 | 2022 | 945 | 1.150 |
Why?
|
| Video Recording | 3 | 2020 | 145 | 1.100 |
Why?
|
| Fear | 3 | 2018 | 239 | 1.090 |
Why?
|
| Motor Vehicles | 2 | 2015 | 20 | 1.010 |
Why?
|
| Substance Abuse, Intravenous | 2 | 2022 | 30 | 1.010 |
Why?
|
| Health Services Accessibility | 8 | 2022 | 581 | 1.000 |
Why?
|
| Hepatitis C, Chronic | 3 | 2022 | 86 | 0.990 |
Why?
|
| United States | 31 | 2022 | 7367 | 0.960 |
Why?
|
| Personal Satisfaction | 5 | 2019 | 123 | 0.950 |
Why?
|
| Surgeons | 4 | 2019 | 68 | 0.920 |
Why?
|
| Altruism | 6 | 2021 | 24 | 0.910 |
Why?
|
| Alcohol Abstinence | 2 | 2013 | 23 | 0.910 |
Why?
|
| Health Promotion | 4 | 2015 | 407 | 0.910 |
Why?
|
| House Calls | 2 | 2014 | 15 | 0.900 |
Why?
|
| Registries | 10 | 2019 | 733 | 0.900 |
Why?
|
| Patient Selection | 6 | 2021 | 592 | 0.900 |
Why?
|
| Internet | 4 | 2017 | 390 | 0.870 |
Why?
|
| Health Status | 8 | 2020 | 429 | 0.860 |
Why?
|
| Informed Consent | 7 | 2017 | 127 | 0.860 |
Why?
|
| Social Support | 8 | 2013 | 423 | 0.840 |
Why?
|
| Health Expenditures | 4 | 2016 | 170 | 0.840 |
Why?
|
| Multivariate Analysis | 12 | 2016 | 1046 | 0.830 |
Why?
|
| Antiviral Agents | 5 | 2022 | 211 | 0.800 |
Why?
|
| Practice Guidelines as Topic | 8 | 2020 | 772 | 0.800 |
Why?
|
| Sleep Wake Disorders | 3 | 2016 | 94 | 0.800 |
Why?
|
| Florida | 13 | 2013 | 221 | 0.780 |
Why?
|
| Tissue Transplantation | 1 | 2021 | 9 | 0.770 |
Why?
|
| Logistic Models | 12 | 2017 | 1420 | 0.770 |
Why?
|
| Family Relations | 3 | 2008 | 47 | 0.760 |
Why?
|
| Aged | 32 | 2021 | 14862 | 0.750 |
Why?
|
| Spouses | 3 | 2011 | 51 | 0.730 |
Why?
|
| Massachusetts | 6 | 2019 | 28 | 0.730 |
Why?
|
| Sick Role | 7 | 2000 | 40 | 0.730 |
Why?
|
| Follow-Up Studies | 20 | 2020 | 3259 | 0.720 |
Why?
|
| Automobile Driving | 3 | 2020 | 88 | 0.700 |
Why?
|
| Adolescent | 38 | 2019 | 8912 | 0.700 |
Why?
|
| Practice Patterns, Physicians' | 4 | 2019 | 504 | 0.690 |
Why?
|
| Cognition | 4 | 2016 | 513 | 0.670 |
Why?
|
| Surgery Department, Hospital | 1 | 2019 | 19 | 0.660 |
Why?
|
| Health Policy | 4 | 2016 | 221 | 0.660 |
Why?
|
| Hospitals, Teaching | 1 | 2019 | 65 | 0.650 |
Why?
|
| Insurance, Health | 3 | 2016 | 201 | 0.630 |
Why?
|
| Aftercare | 1 | 2019 | 114 | 0.630 |
Why?
|
| Financing, Personal | 2 | 2016 | 17 | 0.620 |
Why?
|
| Program Development | 2 | 2019 | 240 | 0.620 |
Why?
|
| Consumer Health Informatics | 1 | 2017 | 1 | 0.600 |
Why?
|
| Blood Group Incompatibility | 2 | 2015 | 7 | 0.600 |
Why?
|
| Cross-Sectional Studies | 13 | 2014 | 2279 | 0.590 |
Why?
|
| Attitude | 6 | 2022 | 121 | 0.590 |
Why?
|
| Population Groups | 1 | 2017 | 16 | 0.590 |
Why?
|
| Prognosis | 9 | 2019 | 2093 | 0.590 |
Why?
|
| Composite Tissue Allografts | 1 | 2017 | 8 | 0.590 |
Why?
|
| Public Opinion | 1 | 2017 | 32 | 0.580 |
Why?
|
| Postoperative Complications | 4 | 2019 | 1615 | 0.580 |
Why?
|
| Comprehension | 1 | 2017 | 71 | 0.570 |
Why?
|
| General Surgery | 1 | 2018 | 95 | 0.570 |
Why?
|
| Time Factors | 15 | 2020 | 4655 | 0.570 |
Why?
|
| Cultural Diversity | 1 | 2017 | 67 | 0.570 |
Why?
|
| Fellowships and Scholarships | 1 | 2018 | 127 | 0.560 |
Why?
|
| Body Image | 1 | 2018 | 100 | 0.560 |
Why?
|
| Child Behavior | 4 | 2009 | 56 | 0.560 |
Why?
|
| Cost of Illness | 5 | 2010 | 206 | 0.550 |
Why?
|
| Risk Assessment | 8 | 2020 | 2007 | 0.550 |
Why?
|
| Patient Preference | 1 | 2017 | 57 | 0.550 |
Why?
|
| Immunosuppressive Agents | 5 | 2016 | 514 | 0.530 |
Why?
|
| Therapeutic Human Experimentation | 1 | 2015 | 6 | 0.530 |
Why?
|
| Ribavirin | 3 | 2011 | 27 | 0.530 |
Why?
|
| Surgical Procedures, Operative | 1 | 2017 | 124 | 0.530 |
Why?
|
| Interferon-alpha | 3 | 2011 | 46 | 0.530 |
Why?
|
| Education, Medical, Graduate | 1 | 2018 | 214 | 0.520 |
Why?
|
| Socioeconomic Factors | 10 | 2017 | 955 | 0.520 |
Why?
|
| Mood Disorders | 3 | 2013 | 132 | 0.520 |
Why?
|
| Social Capital | 1 | 2015 | 4 | 0.520 |
Why?
|
| Total Quality Management | 1 | 2015 | 45 | 0.520 |
Why?
|
| Policy Making | 1 | 2015 | 51 | 0.520 |
Why?
|
| Ethics Committees, Research | 1 | 2015 | 22 | 0.520 |
Why?
|
| Patient Outcome Assessment | 1 | 2015 | 42 | 0.510 |
Why?
|
| Hepacivirus | 2 | 2022 | 90 | 0.510 |
Why?
|
| Renal Dialysis | 7 | 2023 | 174 | 0.510 |
Why?
|
| Prospective Studies | 13 | 2019 | 3705 | 0.510 |
Why?
|
| Alcoholism | 2 | 2013 | 1109 | 0.500 |
Why?
|
| Polyethylene Glycols | 3 | 2011 | 149 | 0.500 |
Why?
|
| ABO Blood-Group System | 1 | 2015 | 15 | 0.500 |
Why?
|
| Emergency Service, Hospital | 1 | 2020 | 711 | 0.470 |
Why?
|
| Child | 33 | 2015 | 6405 | 0.470 |
Why?
|
| Mental Health | 4 | 2015 | 278 | 0.470 |
Why?
|
| End Stage Liver Disease | 2 | 2012 | 60 | 0.470 |
Why?
|
| Consensus | 9 | 2020 | 211 | 0.470 |
Why?
|
| Emotions | 4 | 2020 | 244 | 0.460 |
Why?
|
| Liver Diseases, Alcoholic | 1 | 2013 | 27 | 0.450 |
Why?
|
| Veterans | 1 | 2021 | 904 | 0.450 |
Why?
|
| Minority Groups | 1 | 2015 | 197 | 0.440 |
Why?
|
| Boston | 4 | 2015 | 35 | 0.440 |
Why?
|
| Behavior | 2 | 2011 | 59 | 0.440 |
Why?
|
| Sex Factors | 8 | 2020 | 1266 | 0.440 |
Why?
|
| Treatment Outcome | 13 | 2020 | 7029 | 0.430 |
Why?
|
| Young Adult | 12 | 2020 | 5717 | 0.420 |
Why?
|
| Attitude to Death | 5 | 2021 | 52 | 0.420 |
Why?
|
| Empathy | 2 | 2004 | 45 | 0.410 |
Why?
|
| Internship and Residency | 1 | 2018 | 596 | 0.400 |
Why?
|
| Liver Failure | 1 | 2011 | 27 | 0.400 |
Why?
|
| Defibrillators, Implantable | 3 | 2021 | 329 | 0.390 |
Why?
|
| Severity of Illness Index | 7 | 2011 | 1851 | 0.390 |
Why?
|
| Risk Factors | 14 | 2020 | 5731 | 0.390 |
Why?
|
| Disclosure | 2 | 2011 | 45 | 0.380 |
Why?
|
| Bone Marrow Transplantation | 7 | 2000 | 149 | 0.380 |
Why?
|
| Social Adjustment | 5 | 2011 | 74 | 0.380 |
Why?
|
| Age Factors | 10 | 2020 | 1864 | 0.370 |
Why?
|
| Autistic Disorder | 4 | 1993 | 77 | 0.370 |
Why?
|
| Desensitization, Immunologic | 1 | 2010 | 25 | 0.370 |
Why?
|
| Liver Diseases | 2 | 2011 | 193 | 0.360 |
Why?
|
| Parents | 5 | 2009 | 312 | 0.360 |
Why?
|
| Medication Adherence | 1 | 2013 | 335 | 0.360 |
Why?
|
| Child, Preschool | 17 | 2015 | 3187 | 0.350 |
Why?
|
| Retrospective Studies | 14 | 2022 | 7277 | 0.350 |
Why?
|
| Analysis of Variance | 7 | 2010 | 1040 | 0.340 |
Why?
|
| Renal Insufficiency, Chronic | 3 | 2020 | 161 | 0.330 |
Why?
|
| Heart Transplantation | 5 | 2005 | 328 | 0.330 |
Why?
|
| Psychotherapy | 3 | 2021 | 253 | 0.330 |
Why?
|
| Mothers | 4 | 2000 | 172 | 0.330 |
Why?
|
| Activities of Daily Living | 7 | 2011 | 319 | 0.320 |
Why?
|
| Health Behavior | 4 | 2015 | 458 | 0.310 |
Why?
|
| Income | 3 | 2016 | 167 | 0.310 |
Why?
|
| Efficiency | 2 | 2019 | 49 | 0.310 |
Why?
|
| Random Allocation | 4 | 2019 | 442 | 0.310 |
Why?
|
| Communication | 2 | 2008 | 329 | 0.310 |
Why?
|
| Personality Inventory | 9 | 2001 | 197 | 0.310 |
Why?
|
| Kidney Diseases | 1 | 2010 | 307 | 0.300 |
Why?
|
| Interviews as Topic | 4 | 2010 | 392 | 0.290 |
Why?
|
| Hospitals, Pediatric | 1 | 2008 | 114 | 0.290 |
Why?
|
| Continuity of Patient Care | 3 | 2015 | 170 | 0.290 |
Why?
|
| Psychometrics | 9 | 2018 | 514 | 0.290 |
Why?
|
| Physician-Patient Relations | 2 | 2015 | 261 | 0.280 |
Why?
|
| HIV Infections | 2 | 2013 | 791 | 0.280 |
Why?
|
| Guideline Adherence | 3 | 2019 | 287 | 0.280 |
Why?
|
| Reproducibility of Results | 7 | 2018 | 2077 | 0.280 |
Why?
|
| Motivation | 8 | 2021 | 561 | 0.280 |
Why?
|
| Parenting | 3 | 1997 | 91 | 0.280 |
Why?
|
| Health Care Surveys | 1 | 2007 | 239 | 0.280 |
Why?
|
| Refusal to Participate | 1 | 2006 | 3 | 0.280 |
Why?
|
| Sickness Impact Profile | 2 | 2009 | 27 | 0.270 |
Why?
|
| Evidence-Based Medicine | 4 | 2020 | 438 | 0.270 |
Why?
|
| Home Care Services | 1 | 2006 | 84 | 0.270 |
Why?
|
| Anxiety | 7 | 2014 | 422 | 0.260 |
Why?
|
| Directed Tissue Donation | 3 | 2017 | 5 | 0.260 |
Why?
|
| Truth Disclosure | 2 | 2015 | 48 | 0.250 |
Why?
|
| Clinical Protocols | 2 | 2019 | 172 | 0.250 |
Why?
|
| Decision Support Techniques | 2 | 2020 | 191 | 0.250 |
Why?
|
| Costs and Cost Analysis | 2 | 2016 | 193 | 0.250 |
Why?
|
| Fathers | 2 | 1996 | 16 | 0.240 |
Why?
|
| Adolescent Behavior | 4 | 2019 | 264 | 0.240 |
Why?
|
| Randomized Controlled Trials as Topic | 3 | 2015 | 931 | 0.240 |
Why?
|
| Southeastern United States | 4 | 2008 | 281 | 0.240 |
Why?
|
| Pain | 4 | 2011 | 472 | 0.240 |
Why?
|
| Laparoscopy | 1 | 2006 | 237 | 0.230 |
Why?
|
| Bibliotherapy | 1 | 2003 | 2 | 0.230 |
Why?
|
| Psychology, Adolescent | 4 | 2006 | 38 | 0.230 |
Why?
|
| Psychology, Child | 4 | 2005 | 28 | 0.230 |
Why?
|
| Cultural Competency | 2 | 2015 | 42 | 0.220 |
Why?
|
| Attitude of Health Personnel | 2 | 2018 | 442 | 0.220 |
Why?
|
| Program Evaluation | 2 | 2019 | 502 | 0.220 |
Why?
|
| Self Concept | 4 | 2005 | 132 | 0.220 |
Why?
|
| Reimbursement Mechanisms | 2 | 2015 | 37 | 0.220 |
Why?
|
| Odds Ratio | 3 | 2014 | 880 | 0.220 |
Why?
|
| Neoplasms | 5 | 2001 | 1667 | 0.220 |
Why?
|
| Chronic Disease | 2 | 2000 | 1330 | 0.210 |
Why?
|
| Pulmonary Disease, Chronic Obstructive | 1 | 2005 | 207 | 0.210 |
Why?
|
| Down Syndrome | 3 | 1993 | 120 | 0.210 |
Why?
|
| Clinical Decision-Making | 2 | 2020 | 109 | 0.210 |
Why?
|
| Health Services Research | 1 | 2003 | 209 | 0.200 |
Why?
|
| Delivery of Health Care | 3 | 2015 | 445 | 0.200 |
Why?
|
| Predictive Value of Tests | 4 | 2020 | 1465 | 0.200 |
Why?
|
| Social Desirability | 1 | 2001 | 9 | 0.190 |
Why?
|
| New England | 1 | 2021 | 16 | 0.190 |
Why?
|
| Substance-Related Disorders | 4 | 2020 | 1242 | 0.190 |
Why?
|
| Interferons | 1 | 2001 | 36 | 0.190 |
Why?
|
| Age Distribution | 2 | 2015 | 320 | 0.190 |
Why?
|
| Religion and Medicine | 1 | 2021 | 25 | 0.190 |
Why?
|
| Social Perception | 1 | 2001 | 44 | 0.190 |
Why?
|
| Vascularized Composite Allotransplantation | 1 | 2021 | 17 | 0.190 |
Why?
|
| Case-Control Studies | 2 | 2018 | 1553 | 0.190 |
Why?
|
| Nephrology | 3 | 2015 | 43 | 0.190 |
Why?
|
| Self Efficacy | 2 | 2021 | 199 | 0.190 |
Why?
|
| Ethics, Medical | 1 | 2001 | 86 | 0.180 |
Why?
|
| Patient Satisfaction | 3 | 2014 | 378 | 0.180 |
Why?
|
| Cohort Studies | 4 | 2021 | 2358 | 0.180 |
Why?
|
| Peer Group | 1 | 2001 | 104 | 0.180 |
Why?
|
| Graft Rejection | 3 | 2016 | 458 | 0.180 |
Why?
|
| Obesity | 2 | 2007 | 1076 | 0.180 |
Why?
|
| United States Government Agencies | 1 | 2020 | 4 | 0.180 |
Why?
|
| Infant | 7 | 2015 | 2891 | 0.180 |
Why?
|
| Social Determinants of Health | 1 | 2021 | 96 | 0.180 |
Why?
|
| Television | 1 | 2020 | 28 | 0.180 |
Why?
|
| Patient Compliance | 4 | 2005 | 402 | 0.170 |
Why?
|
| Sunlight | 2 | 1996 | 59 | 0.170 |
Why?
|
| Karnofsky Performance Status | 1 | 2019 | 4 | 0.170 |
Why?
|
| Educational Status | 3 | 2009 | 273 | 0.170 |
Why?
|
| Recombinant Proteins | 3 | 2011 | 742 | 0.170 |
Why?
|
| Aged, 80 and over | 5 | 2020 | 4848 | 0.170 |
Why?
|
| Genetic Testing | 1 | 2020 | 159 | 0.170 |
Why?
|
| Third-Party Consent | 2 | 2009 | 7 | 0.170 |
Why?
|
| Affective Symptoms | 2 | 2011 | 50 | 0.160 |
Why?
|
| Drug Therapy, Combination | 2 | 2011 | 649 | 0.160 |
Why?
|
| Shock | 1 | 2018 | 28 | 0.150 |
Why?
|
| Death | 1 | 2018 | 38 | 0.150 |
Why?
|
| Automobile Driver Examination | 2 | 2015 | 5 | 0.150 |
Why?
|
| Social Behavior | 3 | 2018 | 164 | 0.150 |
Why?
|
| Bioethical Issues | 1 | 2017 | 10 | 0.150 |
Why?
|
| Insurance Coverage | 2 | 2016 | 99 | 0.150 |
Why?
|
| Linear Models | 2 | 2011 | 521 | 0.150 |
Why?
|
| Risk | 3 | 2013 | 563 | 0.150 |
Why?
|
| Heliotherapy | 1 | 1996 | 1 | 0.140 |
Why?
|
| Transplantation, Homologous | 1 | 2017 | 242 | 0.140 |
Why?
|
| Pandemics | 1 | 2020 | 352 | 0.140 |
Why?
|
| Publishing | 1 | 2018 | 89 | 0.140 |
Why?
|
| Colonic Diseases | 1 | 2016 | 36 | 0.140 |
Why?
|
| Child Behavior Disorders | 2 | 2000 | 69 | 0.140 |
Why?
|
| Trust | 1 | 2017 | 75 | 0.140 |
Why?
|
| Health Care Reform | 1 | 2016 | 62 | 0.140 |
Why?
|
| Colectomy | 1 | 2016 | 64 | 0.140 |
Why?
|
| Kaplan-Meier Estimate | 2 | 2017 | 536 | 0.140 |
Why?
|
| Health Plan Implementation | 1 | 2016 | 37 | 0.130 |
Why?
|
| Heart | 1 | 2021 | 850 | 0.130 |
Why?
|
| Autonomic Nervous System | 1 | 2016 | 31 | 0.130 |
Why?
|
| Gift Giving | 1 | 2015 | 10 | 0.130 |
Why?
|
| Health Insurance Portability and Accountability Act | 1 | 2015 | 13 | 0.130 |
Why?
|
| Marriage | 1 | 1996 | 30 | 0.130 |
Why?
|
| Operating Rooms | 1 | 2017 | 108 | 0.130 |
Why?
|
| Social Class | 1 | 2016 | 127 | 0.130 |
Why?
|
| Government Regulation | 1 | 2015 | 46 | 0.130 |
Why?
|
| Self Report | 2 | 2016 | 371 | 0.130 |
Why?
|
| Health Surveys | 2 | 2007 | 489 | 0.130 |
Why?
|
| Ambulatory Care Facilities | 3 | 2015 | 91 | 0.130 |
Why?
|
| Critical Care | 1 | 2018 | 263 | 0.130 |
Why?
|
| Cadaver | 1 | 2015 | 136 | 0.130 |
Why?
|
| Health Personnel | 1 | 2018 | 286 | 0.120 |
Why?
|
| Rhode Island | 1 | 2014 | 9 | 0.120 |
Why?
|
| Causality | 1 | 1995 | 82 | 0.120 |
Why?
|
| Models, Biological | 1 | 2019 | 981 | 0.120 |
Why?
|
| Physician's Role | 1 | 2015 | 116 | 0.120 |
Why?
|
| Polysomnography | 2 | 2016 | 92 | 0.120 |
Why?
|
| Poisson Distribution | 1 | 2014 | 85 | 0.120 |
Why?
|
| Smoking | 5 | 2005 | 1452 | 0.120 |
Why?
|
| Culture | 1 | 2014 | 75 | 0.120 |
Why?
|
| Patient Participation | 2 | 2014 | 146 | 0.120 |
Why?
|
| Alcohol Drinking | 3 | 2013 | 805 | 0.120 |
Why?
|
| Reference Values | 2 | 2014 | 579 | 0.120 |
Why?
|
| Rural Health Services | 1 | 2015 | 101 | 0.120 |
Why?
|
| Adenocarcinoma | 1 | 2017 | 475 | 0.120 |
Why?
|
| Diabetes Mellitus, Type 1 | 3 | 1994 | 529 | 0.120 |
Why?
|
| Sibling Relations | 1 | 1993 | 4 | 0.120 |
Why?
|
| Personality Development | 1 | 1993 | 11 | 0.120 |
Why?
|
| Emergency Medical Services | 1 | 2016 | 225 | 0.120 |
Why?
|
| Research | 1 | 2015 | 214 | 0.110 |
Why?
|
| Pancreatic Neoplasms | 1 | 2017 | 332 | 0.110 |
Why?
|
| Graft Survival | 5 | 2016 | 465 | 0.110 |
Why?
|
| Regression Analysis | 2 | 2014 | 737 | 0.110 |
Why?
|
| Role | 2 | 2010 | 25 | 0.110 |
Why?
|
| Algorithms | 3 | 2014 | 1196 | 0.110 |
Why?
|
| Single-Blind Method | 1 | 2013 | 249 | 0.110 |
Why?
|
| Incidence | 2 | 2014 | 1603 | 0.110 |
Why?
|
| Postoperative Care | 1 | 2013 | 163 | 0.110 |
Why?
|
| Psychotherapy, Brief | 2 | 2005 | 30 | 0.110 |
Why?
|
| Psychomotor Performance | 2 | 2016 | 213 | 0.110 |
Why?
|
| Recurrence | 2 | 2013 | 948 | 0.110 |
Why?
|
| Body Mass Index | 2 | 2020 | 867 | 0.110 |
Why?
|
| Interpersonal Relations | 3 | 2007 | 209 | 0.100 |
Why?
|
| Insurance, Health, Reimbursement | 1 | 2012 | 47 | 0.100 |
Why?
|
| Secondary Prevention | 1 | 2013 | 291 | 0.100 |
Why?
|
| Intention to Treat Analysis | 1 | 2012 | 38 | 0.100 |
Why?
|
| Community Health Services | 1 | 2013 | 141 | 0.100 |
Why?
|
| Histocompatibility Testing | 2 | 2013 | 38 | 0.100 |
Why?
|
| Patient-Centered Care | 1 | 2013 | 106 | 0.100 |
Why?
|
| Research Design | 2 | 2016 | 729 | 0.100 |
Why?
|
| Parent-Child Relations | 2 | 2006 | 98 | 0.100 |
Why?
|
| Patient Readmission | 1 | 2014 | 267 | 0.100 |
Why?
|
| Contraindications | 2 | 2007 | 52 | 0.090 |
Why?
|
| Statistics, Nonparametric | 1 | 2010 | 306 | 0.090 |
Why?
|
| Cognition Disorders | 2 | 2005 | 342 | 0.090 |
Why?
|
| Physicians | 2 | 2009 | 324 | 0.090 |
Why?
|
| Education of Intellectually Disabled | 1 | 1989 | 4 | 0.090 |
Why?
|
| Verbal Behavior | 1 | 1989 | 27 | 0.090 |
Why?
|
| Problem Solving | 1 | 1989 | 36 | 0.090 |
Why?
|
| Primary Health Care | 1 | 2015 | 703 | 0.090 |
Why?
|
| Societies | 1 | 2009 | 15 | 0.090 |
Why?
|
| Sensitivity and Specificity | 1 | 2013 | 1753 | 0.080 |
Why?
|
| Neuropsychological Tests | 3 | 2016 | 517 | 0.080 |
Why?
|
| Nursing Methodology Research | 1 | 2009 | 39 | 0.080 |
Why?
|
| Legal Guardians | 1 | 2009 | 3 | 0.080 |
Why?
|
| Mass Media | 1 | 2009 | 29 | 0.080 |
Why?
|
| Hospitals, University | 1 | 2009 | 169 | 0.080 |
Why?
|
| Proteinuria | 1 | 2009 | 136 | 0.080 |
Why?
|
| Chi-Square Distribution | 1 | 2010 | 546 | 0.080 |
Why?
|
| Health Care Costs | 3 | 2018 | 346 | 0.080 |
Why?
|
| Public Policy | 1 | 2009 | 71 | 0.080 |
Why?
|
| Albuminuria | 1 | 2009 | 171 | 0.080 |
Why?
|
| Depressive Disorder | 3 | 2000 | 621 | 0.080 |
Why?
|
| Sirolimus | 1 | 2009 | 118 | 0.080 |
Why?
|
| Intellectual Disability | 1 | 1989 | 114 | 0.080 |
Why?
|
| Child Development | 2 | 2005 | 102 | 0.080 |
Why?
|
| Patient Care Team | 2 | 2007 | 311 | 0.080 |
Why?
|
| Information Dissemination | 1 | 2009 | 113 | 0.080 |
Why?
|
| Financial Support | 1 | 2007 | 5 | 0.080 |
Why?
|
| Glucose Tolerance Test | 1 | 2007 | 75 | 0.070 |
Why?
|
| Feasibility Studies | 2 | 2020 | 652 | 0.070 |
Why?
|
| Choice Behavior | 1 | 2008 | 85 | 0.070 |
Why?
|
| Employment | 3 | 2016 | 154 | 0.070 |
Why?
|
| Blood Glucose | 2 | 2009 | 631 | 0.070 |
Why?
|
| Medical History Taking | 1 | 2007 | 94 | 0.070 |
Why?
|
| Child of Impaired Parents | 1 | 2006 | 18 | 0.070 |
Why?
|
| Confidentiality | 3 | 2015 | 62 | 0.070 |
Why?
|
| Rural Population | 3 | 2022 | 398 | 0.070 |
Why?
|
| Histocompatibility | 1 | 2006 | 17 | 0.070 |
Why?
|
| Smoking Cessation | 2 | 2006 | 1034 | 0.070 |
Why?
|
| Community-Institutional Relations | 1 | 2006 | 59 | 0.070 |
Why?
|
| Needs Assessment | 2 | 2006 | 186 | 0.070 |
Why?
|
| Proportional Hazards Models | 2 | 2019 | 792 | 0.070 |
Why?
|
| Mental Status Schedule | 1 | 2005 | 31 | 0.070 |
Why?
|
| Recovery of Function | 1 | 2009 | 506 | 0.070 |
Why?
|
| Transportation | 2 | 2016 | 21 | 0.070 |
Why?
|
| Intention | 1 | 2006 | 80 | 0.070 |
Why?
|
| Benchmarking | 2 | 2022 | 91 | 0.070 |
Why?
|
| Spirituality | 1 | 2006 | 38 | 0.070 |
Why?
|
| Respiratory Function Tests | 1 | 2005 | 123 | 0.060 |
Why?
|
| Evaluation Studies as Topic | 1 | 2005 | 219 | 0.060 |
Why?
|
| Psychiatric Status Rating Scales | 2 | 2005 | 782 | 0.060 |
Why?
|
| Comorbidity | 4 | 2014 | 1426 | 0.060 |
Why?
|
| Transplants | 1 | 2005 | 28 | 0.060 |
Why?
|
| Telephone | 1 | 2005 | 160 | 0.060 |
Why?
|
| Adolescent Development | 1 | 2005 | 28 | 0.060 |
Why?
|
| Longitudinal Studies | 3 | 2016 | 1054 | 0.060 |
Why?
|
| Depression | 2 | 2006 | 943 | 0.060 |
Why?
|
| Factor Analysis, Statistical | 2 | 2005 | 201 | 0.060 |
Why?
|
| Nurses | 2 | 1995 | 53 | 0.060 |
Why?
|
| Tobacco Use Disorder | 2 | 2006 | 432 | 0.060 |
Why?
|
| Orientation | 1 | 2004 | 31 | 0.060 |
Why?
|
| Prevalence | 3 | 2020 | 1619 | 0.060 |
Why?
|
| Cooperative Behavior | 2 | 2015 | 235 | 0.060 |
Why?
|
| Antiretroviral Therapy, Highly Active | 1 | 2004 | 73 | 0.060 |
Why?
|
| Survival Rate | 3 | 2012 | 1056 | 0.050 |
Why?
|
| Socialization | 2 | 1993 | 13 | 0.050 |
Why?
|
| Anti-HIV Agents | 1 | 2004 | 135 | 0.050 |
Why?
|
| Hospitalization | 3 | 2016 | 978 | 0.050 |
Why?
|
| Treatment Refusal | 1 | 2002 | 40 | 0.050 |
Why?
|
| Hemodialysis, Home | 1 | 2022 | 1 | 0.050 |
Why?
|
| Stem Cell Transplantation | 1 | 2002 | 58 | 0.050 |
Why?
|
| Forecasting | 1 | 2003 | 277 | 0.050 |
Why?
|
| Skin Neoplasms | 2 | 1996 | 375 | 0.050 |
Why?
|
| Medical Futility | 1 | 2001 | 31 | 0.050 |
Why?
|
| Urination | 1 | 2000 | 19 | 0.050 |
Why?
|
| Urethra | 1 | 2000 | 56 | 0.050 |
Why?
|
| Interrupted Time Series Analysis | 1 | 2020 | 26 | 0.040 |
Why?
|
| Urinary Bladder | 1 | 2000 | 108 | 0.040 |
Why?
|
| Cardiovascular Diseases | 1 | 2007 | 940 | 0.040 |
Why?
|
| Morals | 2 | 2017 | 27 | 0.040 |
Why?
|
| Alabama | 1 | 2020 | 98 | 0.040 |
Why?
|
| Death, Sudden, Cardiac | 1 | 2021 | 141 | 0.040 |
Why?
|
| Databases as Topic | 1 | 1999 | 49 | 0.040 |
Why?
|
| Data Collection | 3 | 2000 | 420 | 0.040 |
Why?
|
| Medicare | 1 | 2021 | 319 | 0.040 |
Why?
|
| Breast Neoplasms | 2 | 2000 | 1536 | 0.040 |
Why?
|
| Plants, Toxic | 1 | 1998 | 33 | 0.040 |
Why?
|
| Tobacco, Smokeless | 1 | 1998 | 40 | 0.040 |
Why?
|
| Quality of Health Care | 1 | 2021 | 322 | 0.040 |
Why?
|
| Pain, Postoperative | 1 | 2020 | 214 | 0.040 |
Why?
|
| Anxiety Disorders | 1 | 2000 | 426 | 0.040 |
Why?
|
| Mother-Child Relations | 1 | 1997 | 43 | 0.040 |
Why?
|
| Survival Analysis | 1 | 2019 | 714 | 0.040 |
Why?
|
| Internal-External Control | 2 | 1994 | 60 | 0.040 |
Why?
|
| Maternal Age | 1 | 1996 | 70 | 0.040 |
Why?
|
| Child Welfare | 1 | 1996 | 53 | 0.030 |
Why?
|
| Dialysis Solutions | 1 | 2016 | 5 | 0.030 |
Why?
|
| Phosphorus | 1 | 2016 | 64 | 0.030 |
Why?
|
| Verbal Learning | 1 | 2016 | 29 | 0.030 |
Why?
|
| Psychology | 1 | 2016 | 36 | 0.030 |
Why?
|
| Marital Status | 1 | 1996 | 65 | 0.030 |
Why?
|
| Organizations | 1 | 2015 | 16 | 0.030 |
Why?
|
| Unsafe Sex | 1 | 2015 | 34 | 0.030 |
Why?
|
| Medical Records | 1 | 2016 | 121 | 0.030 |
Why?
|
| Reaction Time | 1 | 2016 | 170 | 0.030 |
Why?
|
| Hemoglobins | 1 | 2016 | 120 | 0.030 |
Why?
|
| Creatinine | 1 | 2016 | 243 | 0.030 |
Why?
|
| Salaries and Fringe Benefits | 1 | 2015 | 29 | 0.030 |
Why?
|
| Neoplasms, Radiation-Induced | 1 | 1995 | 79 | 0.030 |
Why?
|
| Housing | 1 | 2015 | 38 | 0.030 |
Why?
|
| Intelligence | 1 | 1995 | 45 | 0.030 |
Why?
|
| Efficiency, Organizational | 1 | 2015 | 61 | 0.030 |
Why?
|
| Executive Function | 1 | 2016 | 106 | 0.030 |
Why?
|
| Personality Assessment | 1 | 1994 | 71 | 0.030 |
Why?
|
| Combined Modality Therapy | 1 | 2017 | 951 | 0.030 |
Why?
|
| Family Health | 1 | 1995 | 83 | 0.030 |
Why?
|
| Memory | 1 | 2016 | 214 | 0.030 |
Why?
|
| Cost-Benefit Analysis | 1 | 2016 | 504 | 0.030 |
Why?
|
| Attention | 1 | 2016 | 225 | 0.030 |
Why?
|
| Perioperative Period | 1 | 2013 | 24 | 0.030 |
Why?
|
| Stereotyping | 1 | 1993 | 20 | 0.030 |
Why?
|
| Outpatient Clinics, Hospital | 1 | 1994 | 69 | 0.030 |
Why?
|
| Allografts | 1 | 2013 | 63 | 0.030 |
Why?
|
| HIV Seropositivity | 1 | 1993 | 66 | 0.030 |
Why?
|
| Patient Care | 1 | 1993 | 61 | 0.030 |
Why?
|
| Referral and Consultation | 1 | 2015 | 383 | 0.030 |
Why?
|
| Models, Theoretical | 1 | 2016 | 384 | 0.030 |
Why?
|
| Transplantation | 1 | 2012 | 23 | 0.030 |
Why?
|
| Preoperative Care | 1 | 1994 | 275 | 0.030 |
Why?
|
| Child Rearing | 1 | 1992 | 8 | 0.030 |
Why?
|
| Father-Child Relations | 1 | 1992 | 6 | 0.030 |
Why?
|
| Physicians, Primary Care | 1 | 2012 | 46 | 0.030 |
Why?
|
| Canada | 1 | 2013 | 267 | 0.030 |
Why?
|
| Urban Population | 1 | 2013 | 255 | 0.030 |
Why?
|
| Melanoma | 1 | 1995 | 335 | 0.030 |
Why?
|
| Monte Carlo Method | 1 | 2012 | 124 | 0.020 |
Why?
|
| Language Development Disorders | 1 | 1991 | 9 | 0.020 |
Why?
|
| Students | 1 | 1993 | 233 | 0.020 |
Why?
|
| Length of Stay | 1 | 2013 | 780 | 0.020 |
Why?
|
| Imitative Behavior | 1 | 1989 | 4 | 0.020 |
Why?
|
| Form Perception | 1 | 1989 | 16 | 0.020 |
Why?
|
| Concept Formation | 1 | 1989 | 16 | 0.020 |
Why?
|
| Calcineurin Inhibitors | 1 | 2009 | 24 | 0.020 |
Why?
|
| Infant, Newborn | 1 | 2015 | 2455 | 0.020 |
Why?
|
| Cyclosporine | 1 | 2009 | 121 | 0.020 |
Why?
|
| Computer Simulation | 1 | 2012 | 706 | 0.020 |
Why?
|
| Glomerular Filtration Rate | 1 | 2009 | 274 | 0.020 |
Why?
|
| Health Status Disparities | 1 | 2011 | 326 | 0.020 |
Why?
|
| Tacrolimus | 1 | 2009 | 127 | 0.020 |
Why?
|
| Life Change Events | 2 | 2003 | 223 | 0.020 |
Why?
|
| Existentialism | 1 | 2006 | 3 | 0.020 |
Why?
|
| Beneficence | 1 | 2006 | 9 | 0.020 |
Why?
|
| Licensure | 1 | 2006 | 18 | 0.020 |
Why?
|
| Placebos | 1 | 2007 | 195 | 0.020 |
Why?
|
| Decision Trees | 1 | 2006 | 74 | 0.020 |
Why?
|
| Pilot Projects | 2 | 2000 | 1342 | 0.020 |
Why?
|
| Hypertension | 1 | 2015 | 1535 | 0.020 |
Why?
|
| Pancreas Transplantation | 1 | 2006 | 71 | 0.020 |
Why?
|
| Health Services Needs and Demand | 1 | 2006 | 149 | 0.020 |
Why?
|
| Cluster Analysis | 2 | 1997 | 219 | 0.020 |
Why?
|
| Patient Simulation | 1 | 2005 | 64 | 0.020 |
Why?
|
| Viral Load | 1 | 2004 | 127 | 0.010 |
Why?
|
| Drug Monitoring | 1 | 2004 | 107 | 0.010 |
Why?
|
| Occupations | 1 | 2003 | 27 | 0.010 |
Why?
|
| Pediatrics | 1 | 2007 | 341 | 0.010 |
Why?
|
| Organizational Objectives | 1 | 2003 | 70 | 0.010 |
Why?
|
| Models, Psychological | 1 | 2003 | 180 | 0.010 |
Why?
|
| Teaching | 1 | 2003 | 169 | 0.010 |
Why?
|
| Urodynamics | 1 | 2000 | 43 | 0.010 |
Why?
|
| Mass Screening | 1 | 2006 | 843 | 0.010 |
Why?
|
| Complementary Therapies | 1 | 2000 | 43 | 0.010 |
Why?
|
| Radiography | 1 | 2000 | 572 | 0.010 |
Why?
|
| Health | 1 | 1998 | 26 | 0.010 |
Why?
|
| Forced Expiratory Volume | 1 | 1998 | 87 | 0.010 |
Why?
|
| Education | 1 | 1998 | 83 | 0.010 |
Why?
|
| Assertiveness | 1 | 1997 | 6 | 0.010 |
Why?
|
| Escape Reaction | 1 | 1997 | 10 | 0.010 |
Why?
|
| Sampling Studies | 1 | 1997 | 80 | 0.010 |
Why?
|
| Chemotherapy, Adjuvant | 1 | 1997 | 129 | 0.010 |
Why?
|
| Clinical Trials as Topic | 1 | 2000 | 848 | 0.010 |
Why?
|
| Manifest Anxiety Scale | 1 | 1994 | 1 | 0.010 |
Why?
|
| Neoplasm Staging | 1 | 1997 | 800 | 0.010 |
Why?
|
| Psychological Tests | 1 | 1994 | 96 | 0.010 |
Why?
|
| Defense Mechanisms | 1 | 1994 | 14 | 0.010 |
Why?
|
| Helplessness, Learned | 1 | 1994 | 9 | 0.010 |
Why?
|
| Parental Notification | 1 | 1993 | 1 | 0.010 |
Why?
|
| Universal Precautions | 1 | 1993 | 5 | 0.010 |
Why?
|
| Duty to Warn | 1 | 1993 | 2 | 0.010 |
Why?
|
| Observer Variation | 1 | 1994 | 330 | 0.010 |
Why?
|
| Disease-Free Survival | 1 | 1994 | 349 | 0.010 |
Why?
|
| Patients | 1 | 1993 | 69 | 0.010 |
Why?
|
| Education, Nursing | 1 | 1993 | 55 | 0.010 |
Why?
|
| Occupational Exposure | 1 | 1993 | 122 | 0.010 |
Why?
|
| Education, Medical | 1 | 1993 | 147 | 0.010 |
Why?
|
| Peptic Ulcer | 1 | 1990 | 37 | 0.010 |
Why?
|